Literature DB >> 22462628

Management of pain in the elderly at the end of life.

Eric Prommer1, Brandy Ficek.   

Abstract

Pain is one of the symptoms most frequently encountered in elderly patients at the end of life. The management of pain in the elderly in general has been associated with undertreatment. The geriatric population has been identified as a challenging population with respect to pain management because of issues related to co-morbidities, polypharmacy and cognitive dysfunction. In the geriatric population, the assessment of pain requires measurement of pain intensity, delineation of opioid responsiveness, and clarification of the impact of pain on patients' psychological, social, spiritual and existential domains. Effective pain management is guided by the World Health Organization (WHO) analgesic stepladder, which categorizes pain intensity according to severity and recommends analgesic agents based on their strength and works effectively in the elderly patient population. Step 1 is reserved for mild pain. Patients in this category are treated with nonopioid analgesics such as acetaminophen, or a nonsteroidal anti-inflammatory, with consideration of an adjuvant analgesic if necessary. Step 2 is reserved for patients experiencing mild to moderate pain who are already taking a nonopioid analgesic, with or without an adjuvant analgesic, but are still experiencing poor analgesic control. Step 2 agents include acetaminophen products containing hydrocodone, oxycodone, codeine and tramadol. Patients with moderate to severe pain require strong analgesics belonging to step 3 of the WHO analgesic stepladder. Step 3 opioids include morphine, hydromorphone, fentanyl, levorphanol, methadone and oxycodone. Familiarity with opioid pharmacokinetics, equianalgesic dosing and adverse effects is necessary for the safe and effective use of these drugs. The appropriate use of adjuvant analgesics such as antiepileptic drugs, antidepressants and local anaesthetics can enhance the use of opioids, especially in cases where opioid responsiveness may be in question, such as with neuropathic pain. This paper will provide an overview of the analgesic considerations for elderly patients at the end of life.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22462628     DOI: 10.2165/11599210-000000000-00000

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  137 in total

Review 1.  [Tolerance and safety of tramadol use. Results of international studies and data from drug surveillance].

Authors:  M Cossmann; C Kohnen; R Langford; C McCartney
Journal:  Drugs       Date:  1997       Impact factor: 9.546

Review 2.  NMDA receptors as targets for drug action in neuropathic pain.

Authors:  C G Parsons
Journal:  Eur J Pharmacol       Date:  2001-10-19       Impact factor: 4.432

3.  Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial.

Authors:  S H Sindrup; F W Bach; C Madsen; L F Gram; T S Jensen
Journal:  Neurology       Date:  2003-04-22       Impact factor: 9.910

4.  High-dose tramadol in comparison to low-dose morphine for cancer pain relief.

Authors:  S Grond; L Radbruch; T Meuser; G Loick; R Sabatowski; K A Lehmann
Journal:  J Pain Symptom Manage       Date:  1999-09       Impact factor: 3.612

5.  The opioid-sparing effects of intravenous ketorolac as an adjuvant analgesic in cancer pain: application in bone metastases and the opioid bowel syndrome.

Authors:  S K Joishy; D Walsh
Journal:  J Pain Symptom Manage       Date:  1998-11       Impact factor: 3.612

Review 6.  Nasal administration of opioids for pain management in adults.

Authors:  O Dale; R Hjortkjaer; E D Kharasch
Journal:  Acta Anaesthesiol Scand       Date:  2002-08       Impact factor: 2.105

7.  Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled trial, N01C3.

Authors:  Ravi D Rao; Patrick J Flynn; Jeff A Sloan; Gilbert Y Wong; Paul Novotny; David B Johnson; Howard M Gross; Samer I Renno; Mohammed Nashawaty; Charles L Loprinzi
Journal:  Cancer       Date:  2008-06-15       Impact factor: 6.860

Review 8.  Ketamine.

Authors:  B Sinner; B M Graf
Journal:  Handb Exp Pharmacol       Date:  2008

9.  Codeine/acetaminophen and hydrocodone/acetaminophen combination tablets for the management of chronic cancer pain in adults: a 23-day, prospective, double-blind, randomized, parallel-group study.

Authors:  René Fernando Rodriguez; Javier Mauricio Castillo; Maria Del Pilar Castillo; Paola Daza Nuñez; Mario Fernando Rodriguez; José Manuel Restrepo; Jorge Martin Rodriguez; Yamileth Ortiz; Ana Maria Angel
Journal:  Clin Ther       Date:  2007-04       Impact factor: 3.393

10.  Amitriptyline in neuropathic cancer pain in patients on morphine therapy: a randomized placebo-controlled, double-blind crossover study.

Authors:  Sebastiano Mercadante; Edoardo Arcuri; Walter Tirelli; Patrizia Villari; Alessandra Casuccio
Journal:  Tumori       Date:  2002 May-Jun
View more
  11 in total

1.  Methadone patient-controlled analgesia for postoperative pain: a randomized, controlled, double-blind study.

Authors:  José Osvaldo Barbosa Neto; Maria Deneb Tavares Machado; Marta de Almeida Correa; Hamilton Alves Scomparim; Irimar Paula Posso; Hazem Adel Ashmawi
Journal:  J Anesth       Date:  2014-01-21       Impact factor: 2.078

2.  Effects of μ-opioid receptor agonists in assays of acute pain-stimulated and pain-depressed behavior in male rats: role of μ-agonist efficacy and noxious stimulus intensity.

Authors:  Ahmad A Altarifi; Kenner C Rice; S Stevens Negus
Journal:  J Pharmacol Exp Ther       Date:  2014-11-18       Impact factor: 4.030

Review 3.  Pain in the Frail or Elderly Patient: Does Tapentadol Have a Role?

Authors:  Felicity C Veal; Gregory M Peterson
Journal:  Drugs Aging       Date:  2015-06       Impact factor: 3.923

4.  Polypharmacy in the elderly from the clinical toxicologist perspective.

Authors:  H J Heppner; M Christ; M Gosch; W Mühlberg; P Bahrmann; T Bertsch; C Sieber; K Singler
Journal:  Z Gerontol Geriatr       Date:  2012-08       Impact factor: 1.281

5.  The effect of opioids on the cognitive function of older adults: results from the Personality and Total Health through life study.

Authors:  Malinee Neelamegam; Janice Zgibor; Henian Chen; Kathleen O'rourke; Chighaf Bakour; Lakshminarayan Rajaram; Kaarin J Anstey
Journal:  Age Ageing       Date:  2021-09-11       Impact factor: 10.668

6.  The efficacy of pregabalin for the management of postoperative pain in primary total knee and hip arthroplasty: a meta-analysis.

Authors:  Fei Li; Jianxiong Ma; Mingjie Kuang; Xuan Jiang; Ying Wang; Bin Lu; Xingwen Zhao; Lei Sun; Xinlong Ma
Journal:  J Orthop Surg Res       Date:  2017-03-24       Impact factor: 2.359

7.  The Efficacy and Safety of Celecoxib for Pain Management After Total Knee Arthroplasty: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Xiaoyuan Geng; Shangyou Zhou; Xiaoyan Zhang; Xi Liu; Xu Cheng; Lihua Jiang; Donghang Zhang
Journal:  Front Surg       Date:  2022-01-28

8.  Administering anticipatory medications in end-of-life care: a qualitative study of nursing practice in the community and in nursing homes.

Authors:  Eleanor Wilson; Hazel Morbey; Jayne Brown; Sheila Payne; Clive Seale; Jane Seymour
Journal:  Palliat Med       Date:  2014-07-28       Impact factor: 4.762

9.  Prevalence of Different Combinations of Antiepileptic Drugs and CNS Drugs in Elderly Home Care Service and Nursing Home Patients in Norway.

Authors:  Kjell H Halvorsen; Cecilie Johannessen Landmark; Anne Gerd Granas
Journal:  Epilepsy Res Treat       Date:  2016-07-20

Review 10.  Pharmacotherapy of Pain in the Older Population: The Place of Opioids.

Authors:  Milica Prostran; Katarina Savić Vujović; Sonja Vučković; Branislava Medić; Dragana Srebro; Nevena Divac; Radan Stojanović; Aleksandar Vujović; Lepa Jovanović; Ana Jotić; Nataša Cerovac
Journal:  Front Aging Neurosci       Date:  2016-06-16       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.